RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Meridian Bioscience Stock

Meridian Bioscience Liabilities 2024

Meridian Bioscience Liabilities

95.04 M USD

Ticker

VIVO

ISIN

US5895841014

WKN

871583

In 2024, Meridian Bioscience's total liabilities amounted to 95.04 M USD, a -21.73% difference from the 121.42 M USD total liabilities in the previous year.

Meridian Bioscience Aktienanalyse

What does Meridian Bioscience do?

Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Meridian Bioscience's Liabilities

Meridian Bioscience's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Meridian Bioscience's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Meridian Bioscience's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Meridian Bioscience's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Meridian Bioscience’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Meridian Bioscience stock

What is the level of liabilities of Meridian Bioscience this year?

Meridian Bioscience has a debt balance of 95.04 M USD this year.

What were the liabilities of Meridian Bioscience compared to the previous year?

The liabilities of Meridian Bioscience have increased by -21.73% dropped compared to the previous year.

What are the consequences of high debt for investors of Meridian Bioscience?

High liabilities can pose a risk for investors of Meridian Bioscience, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Meridian Bioscience?

Low liabilities mean that Meridian Bioscience has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Meridian Bioscience affect the company?

An increase in liabilities of Meridian Bioscience can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Meridian Bioscience affect the company?

A decrease in the liabilities of Meridian Bioscience can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Meridian Bioscience?

Some factors that can influence the liabilities of Meridian Bioscience include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Meridian Bioscience so important for investors?

The liabilities of Meridian Bioscience are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Meridian Bioscience take to modify the liabilities?

To change its liabilities, Meridian Bioscience can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Meridian Bioscience pay?

Over the past 12 months, Meridian Bioscience paid a dividend of 0.13 USD . This corresponds to a dividend yield of about 0.37 %. For the coming 12 months, Meridian Bioscience is expected to pay a dividend of 0.24 USD.

What is the dividend yield of Meridian Bioscience?

The current dividend yield of Meridian Bioscience is 0.37 %.

When does Meridian Bioscience pay dividends?

Meridian Bioscience pays a quarterly dividend. This is distributed in the months of June, September, December, March.

How secure is the dividend of Meridian Bioscience?

Meridian Bioscience paid dividends every year for the past 3 years.

What is the dividend of Meridian Bioscience?

For the upcoming 12 months, dividends amounting to 0.24 USD are expected. This corresponds to a dividend yield of 0.7 %.

In which sector is Meridian Bioscience located?

Meridian Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Meridian Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Meridian Bioscience from 2/14/2019 amounting to 0.125 USD, you needed to have the stock in your portfolio before the ex-date on 2/1/2019.

When did Meridian Bioscience pay the last dividend?

The last dividend was paid out on 2/14/2019.

What was the dividend of Meridian Bioscience in the year 2023?

In the year 2023, Meridian Bioscience distributed 0 USD as dividends.

In which currency does Meridian Bioscience pay out the dividend?

The dividends of Meridian Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Meridian Bioscience stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Meridian Bioscience

Our stock analysis for Meridian Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Meridian Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.